Skip to content
10-Q

Quarterly Report

NEUROPATHIX, INC.

0001607062-21-000117

← back to feed
Filed
May 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 11, 2021 87.98M sh
Short Term Debt Q1 2021 · Mar 31, 2021 $42.09K
Short Term Debt Q1 2021 · Dec 31, 2020 $42.09K
Current Liabilities Q1 2021 · Mar 31, 2021 $2.44M
Current Liabilities Q1 2021 · Dec 31, 2020 $2.55M
Total Liabilities Q1 2021 · Mar 31, 2021 $3.25M
Total Liabilities Q1 2021 · Dec 31, 2020 $3.45M
Current Assets Q1 2021 · Mar 31, 2021 $418.03K
Current Assets Q1 2021 · Dec 31, 2020 $183.27K
Total Assets Q1 2021 · Mar 31, 2021 $514.61K
Total Assets Q1 2021 · Dec 31, 2020 $259.66K
Long Term Debt Q1 2021 · Dec 31, 2020 $950K
Capex Q1 2021 · Mar 31, 2020 $0
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$349.07K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $114.58K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $121.46K
Stockholders Equity Q1 2021 · Mar 31, 2020 −$2M
Stockholders Equity Q1 2021 · Dec 31, 2019 −$1.69M
Sga Expense Q1 2021 · Mar 31, 2020 $364.11K
Rd Expense Q1 2021 · Mar 31, 2020 $19.73K
Net Income Q1 2021 · Mar 31, 2020 −$307.83K
Operating Income Q1 2021 · Mar 31, 2020 −$383.83K
Revenue Q1 2021 · Mar 31, 2020 $0